FinancialsNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 2019505HIT stock profile & AI dashboard →

13F Pro Quality Score

38.7/100

Rank #2,181 of 2,962 stocks

View Financials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

85.3/100

Profitability

17.0/100

Balance Sheet

13.2/100

Earnings Quality

4.5/100

Free Cash Flow

14.6/100

Institutional Flow

97.8/100

Revenue Scale

5.8/100

Dilution Risk

25.8/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Unusual Activity in HIT

Events flagged as statistical outliers against HIT's own multi-year baseline — not fixed dollar thresholds.

HIT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Health In Tech, Inc. (HIT), a Financials sector company. 13F Pro's AI-powered ranking engine scores HIT at 38.7/100 on a 32-signal composite quality model, placing it at rank #2,181 of 2,962 stocks — the bottom half of the AI-ranked universe. HIT scores in the top quartile across institutional flow (97.8), revenue growth (85.3). Areas of concern include earnings quality (4.5) and revenue scale (5.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 25.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Health In Tech, Inc. reports quarterly revenue of $8.1M, net income of $-2.5M. Top institutional holders of HIT by reported 13-F value include Whetstone Capital Advisors, Mink Brook Asset Management, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. HIT trades on the Nasdaq exchange and files with the SEC under CIK 2019505. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Health In Tech, Inc. directly from SEC EDGAR. Health In Tech, Inc.'s 13F Pro composite quality score has ranged between 39 and 59 since 2026, currently 38.7 — a declining long-term trajectory across 25 quarterly and live scoring snapshots.

Revenue

Q2 2026

$8.1M

Net Income

Q2 2026

$-2.5M

ROIC

Q2 2026

-67.7%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+71.0% YoY
$33.3MFY 2025
FY22 FY23 $19.2MFY24 $19.5MFY25 $33.3M

Net Income

+90.7% YoY
$1.3MFY 2025
FY22 FY23 FY24 $670.5KFY25 $1.3M

EPS (Diluted)

+100.0% YoY
$0.02FY 2025
FY22 FY23 FY24 $0.01FY25 $0.02

Total Assets

+46.4% YoY
$23.1MFY 2025
FY22 FY23 $11.5MFY24 $15.8MFY25 $23.1M

Op. Cash Flow

+44.0% YoY
$3.1MFY 2025
FY22 FY23 $1.5MFY24 $2.2MFY25 $3.1M

Get alerted when HIT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Health In Tech, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of HIT

Companies Similar to HIT

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

NAII

NATURAL ALTERNATIVES INTERNATIONAL INC

27
AI score
Shared smart-money ownership · 1 shared holders
GEMI

Gemini Space Station, Inc.

39
AI score
Similar quality profile
DGXX

Digi Power X Inc.

17
AI score
Similar quality profile
ALTI

AlTi Global, Inc.

42
AI score
Similar quality profile
ABTC

American Bitcoin Corp.

44
AI score
Similar quality profile
WYFI

WhiteFiber, Inc.

37
AI score
Similar quality profile
FWDI

Forward Industries, Inc.

33
AI score
Similar quality profile
AVX

AVAX ONE TECHNOLOGY LTD.

33
AI score
Similar quality profile

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put HIT on your watchlist

Track score changes the day Health In Tech, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is HIT a good stock to buy?

13F Pro's AI-powered analysis of Health In Tech, Inc. (HIT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for HIT are available on the HIT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. HIT is classified as a small company.

Which hedge funds own HIT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling HIT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Health In Tech, Inc.'s investment landscape.